SHINYA YAMAMOTO to Imatinib Mesylate
This is a "connection" page, showing publications SHINYA YAMAMOTO has written about Imatinib Mesylate.
Connection Strength
0.048
-
Focal Segmental Sclerosis Associated with the Novel Multi-tyrosine Kinase Inhibitor Ponatinib. Intern Med. 2023 Sep 15; 62(18):2693-2698.
Score: 0.048
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.